APA (7th ed.) Citation

Robak, T., Huang, H., Jin, J., Zhu, J., Liu, T., Samoilova, O., . . . Cavalli, F. (2019). Association between bortezomib dose intensity and overall survival in mantle cell lymphoma patients on frontline VR-CAP in the phase 3 LYM-3002 study*. Leukemia & Lymphoma, 60(1), 172. https://doi.org/10.1080/10428194.2017.1321750

Chicago Style (17th ed.) Citation

Robak, Tadeusz, et al. "Association Between Bortezomib Dose Intensity and Overall Survival in Mantle Cell Lymphoma Patients on Frontline VR-CAP in the Phase 3 LYM-3002 Study*." Leukemia & Lymphoma 60, no. 1 (2019): 172. https://doi.org/10.1080/10428194.2017.1321750.

MLA (9th ed.) Citation

Robak, Tadeusz, et al. "Association Between Bortezomib Dose Intensity and Overall Survival in Mantle Cell Lymphoma Patients on Frontline VR-CAP in the Phase 3 LYM-3002 Study*." Leukemia & Lymphoma, vol. 60, no. 1, 2019, p. 172, https://doi.org/10.1080/10428194.2017.1321750.